Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim
Cancer Res Treat. 2015;47(3):343-361.   Published online 2015 May 18     DOI: https://doi.org/10.4143/crt.2014.308
Citations to this article as recorded by Crossref logo
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Tho
Zeitschrift für Gastroenterologie.2024; 62(01): 73.     CrossRef
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Tho
Zeitschrift für Gastroenterologie.2024; 62(01): e67.     CrossRef
Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone
Masaaki Kagoura, Shin Kobayashi, Motohiro Kojima, Masashi Kudo, Motokazu Sugimoto, Masaru Konishi, Naoto Gotohda
European Journal of Surgical Oncology.2024; 50(3): 107980.     CrossRef
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Sabrina Groß, Michael Bitzer, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Tho
Zeitschrift für Gastroenterologie.2024; 62(02): e213.     CrossRef
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion
Michael Bitzer, Sabrina Groß, Jörg Albert, Susanne Blödt, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Markus Follmann, Paul Freudenberger, Cihan Gani, Andreas Geier, Eleni Gkika, Martin Götz, Tho
Zeitschrift für Gastroenterologie.2024; 62(02): 231.     CrossRef
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
Howard A Burris, Takuji Okusaka, Arndt Vogel, Myung Ah Lee, Hidenori Takahashi, Valeriy Breder, Jean-Frédéric Blanc, Junhe Li, Melinda Bachini, Magdalena Żotkiewicz, Jayne Abraham, Nikunj Patel, Julie Wang, Muzammil Ali, Nana Rokutanda, Gordon Cohen, Do-Y
The Lancet Oncology.2024; 25(5): 626.     CrossRef
Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models
Niranjan Awasthi, Lily Darman, Margaret A. Schwarz, Roderich E. Schwarz
Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer
Tian-mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-jie Tao, Xi-yun Chen, Qin Han, Zhuo Cheng, Pei-pei Shang, Yu-long Dong, He-ming Xu, Lie-ping Guo, Dong-sheng Chen, Yun-jie Song, Chuang Qi, Wang-long Deng, Zhen-gang Yuan
Nature Communications.2023;[Epub]     CrossRef
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kau
Zeitschrift für Gastroenterologie.2023; 61(04): e92.     CrossRef
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome
Michael Bitzer, Sabrina Groß, Jörg Albert, Judit Boda-Heggemann, Thomas Brunner, Reiner Caspari, Enrico De Toni, Frank Dombrowski, Matthias Evert, Andreas Geier, Eleni Gkika, Martin Götz, Thomas Helmberger, Ralf-Thorsten Hoffmann, Peter Huppert, Achim Kau
Zeitschrift für Gastroenterologie.2023; 61(04): 420.     CrossRef
Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer
Susanna Slater, David Cunningham
The Lancet.2023; 401(10391): 1826.     CrossRef
Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
Jihye L. Golino, Xin Wang, Jing Bian, Benjamin Ruf, Michael Kelly, Baktiar O. Karim, Maggie C. Cam, Changqing Xie
Cancers.2023; 15(9): 2454.     CrossRef
Very rare metastatic phenomena of biliary tract cancer to the cerebellum: A case report and review of the literature
Oadi N. Shrateh, Shadi Abu Saa
International Journal of Surgery Case Reports.2023; 111: 108819.     CrossRef
Comparison of Efficacy and Safety of Anti-Programmed Cell Death-1 Antibody Plus Lenvatinib and Chemotherapy as First-Line Therapy for Patients with Stage IV Gallbladder Cancer: A Real-World Study in a Chinese Population
Tiantian Wu, Changsheng Pu, Qiang Wang, Keming Zhang
Biomedicines.2023; 11(11): 2933.     CrossRef
Effectivity of Palliative Care Bundle on Advanced Gallbladder Cancer: A Randomised Controlled Trial
Kusum K. Rohilla, C. Vasantha Kalyani, Amit Gupta, Manoj Gupta, Nirmal Matella
Indian Journal of Palliative Care.2023; 29: 447.     CrossRef
Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literature
Wen-Hui Luo, Shao-Jun Li, Xue-Feng Wang
World Journal of Gastrointestinal Oncology.2023; 15(11): 2033.     CrossRef
S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome
M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A
Zeitschrift für Gastroenterologie.2022; 60(02): e186.     CrossRef
S3-Leitlinie: Diagnostik und Therapie biliärer Karzinome
M. Bitzer, S. Voesch, J. Albert, P. Bartenstein, W. Bechstein, S. Blödt, T. Brunner, F. Dombrowski, M. Evert, M. Follmann, C. La Fougère, P. Freudenberger, A. Geier, E. Gkika, M. Götz, E. Hammes, T. Helmberger, R. T. Hoffmann, W. P. Hofmann, P. Huppert, A
Zeitschrift für Gastroenterologie.2022; 60(02): 219.     CrossRef
Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma
Jianyang Fu, Nicole A McGrath, Jihye Lee, Xin Wang, Gagandeep Brar, Changqing Xie
Hepatobiliary & Pancreatic Diseases International.2022; 21(5): 485.     CrossRef
Cytotoxic activities of ethanolic crude extracts from fruiting bodies of bamboo mushrooms (Dictyophora spp.) against cholangiocarcinoma cells
Pathanin Chantree, Sirilak Chumkiew, Mantana Jamklang, Pongsakorn Martviset
Research Results in Pharmacology.2022; 8(1): 33.     CrossRef
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation
Eunsil Sung, Minkyung Ko, Ju-young Won, Yunju Jo, Eunyoung Park, Hyunjoo Kim, Eunji Choi, Ui-jung Jung, Jaehyoung Jeon, Youngkwang Kim, Hyejin Ahn, Da-som Choi, Seunghyun Choi, Youngeun Hong, Hyeyoung Park, Hanbyul Lee, Yong-Gyu Son, Kyeongsu Park, Jonghw
Molecular Therapy.2022; 30(8): 2800.     CrossRef
Toripalimab in advanced biliary tract cancer
Wei Li, Yueqi Wang, Yiyi Yu, Qian Li, Yan Wang, Chenlu Zhang, Xiaojing Xu, Xi Guo, Yu Dong, Yuehong Cui, Qing Hao, Lujia Huang, Houbao Liu, Tianshu Liu
The Innovation.2022; 3(4): 100255.     CrossRef
Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy
Sedighe Hosseini Shabanan, Nariman Nezami, Mohamed E. Abdelsalam, Rahul Anil Sheth, Bruno C. Odisio, Armeen Mahvash, Peiman Habibollahi
Current Oncology.2022; 29(6): 3825.     CrossRef
Can patients with gallbladder adenocarcinoma and liver metastases obtain survival benefit from surgery? A population-based study
Tianming Gao, Hua Tang, Baohuan Zhou, Dousheng Bai, Shengjie Jin, Chi Zhang, Guoqing Jiang
Updates in Surgery.2022; 74(4): 1353.     CrossRef
Pharmacophore Based Design of Probable FGFR-1 Inhibitors from the 3D Crystal Structure of Infigratinib - A Drug Used in the Treatment of Cholangiocarcinomas
Koushik Sarker , Avijit Ghosh , Abhijit Saha, Suvasish Mishra, Subrata Sen
Letters in Drug Design & Discovery.2022; 19(4): 314.     CrossRef
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
Michael J. Viereckl, Kelsey Krutsinger, Aaron Apawu, Jian Gu, Bryana Cardona, Donovan Barratt, Yuyan Han
Biomolecules.2022; 12(6): 854.     CrossRef
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine–cisplatin treatment
Karlijn Verkerk, Hans-Martin Otten, Alwin D. R. Huitema
Cancer Chemotherapy and Pharmacology.2022; 90(5): 417.     CrossRef
Enhanced gemcitabine cytotoxicity with knockdown of multidrug resistance protein genes in human cholangiocarcinoma cell lines
Jiaqi Yang, David Sontag, Yuewen Gong, Gerald Y Minuk
Journal of Gastroenterology and Hepatology.2021; 36(4): 1103.     CrossRef
Biliary tract cancer
Juan W Valle, R Katie Kelley, Bruno Nervi, Do-Youn Oh, Andrew X Zhu
The Lancet.2021; 397(10272): 428.     CrossRef
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
Changhoon Yoo, Sang Hyun Shin, Joon-Oh Park, Kyu-Pyo Kim, Jae Ho Jeong, Baek-Yeol Ryoo, Woohyung Lee, Ki-Byung Song, Dae-Wook Hwang, Jin-hong Park, Jae Hoon Lee
Cancers.2021; 13(7): 1647.     CrossRef
Thoracoscopic metastasectomy is the method of choice in the stepwise treatment of disseminated cholangiocellular carcinoma
A.A. Pechetov, A.V. Chzhao, Sh.V. Ragimov, D.A. Volchansky, M.A. Makov, B.N. Gurmikov
Onkologiya. Zhurnal imeni P.A.Gertsena.2021; 10(2): 39.     CrossRef
IGF2BP1 IS A POOR PROGNOSTIC FACTOR IN EXTRAHEPATIC CHOLANGIOCARCINOMA
Hung-Chune Maa, Yi-No Wu
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021; : 80.     CrossRef
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma
Lynn E. Nooijen, Lotte C. Franken, Ali Belkouz, Ikrame Oulad Abdennabi, Marc G. Besselink, Olivier R. Busch, Rutger-Jan Swijnenburg, Heinz-Josef Klümpen, Joris I. Erdmann
American Journal of Clinical Oncology.2021; 44(10): 526.     CrossRef
Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1
Ranu S Sinniah, Mark S Shapses, Mohammad Umar Ahmed, Hani Babiker, Sreenivasa R. Chandana
Expert Opinion on Investigational Drugs.2021; 30(10): 1047.     CrossRef
RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin
Jung Won Chun, Boyoung Lee, Weon Seo Park, Nayoung Han, Eun Kyung Hong, Eun Young Park, Sung Sik Han, Sang-Jae Park, Tae Hyun Kim, Woo Jin Lee, Sang Myung Woo
Journal of Clinical Medicine.2021; 10(20): 4652.     CrossRef
Effect of Photodynamic Therapy on Gemcitabine-Resistant Cholangiocarcinoma in vitro and in vivo Through KLF10 and EGFR
Yang Yang, Jigang Li, Lei Yao, Lile Wu
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study
Qiyi Zhang, Xingyu Liu, Shumei Wei, Lufei Zhang, Yang Tian, Zhenzhen Gao, Ming Jin, Sheng Yan
Frontiers in Oncology.2021;[Epub]     CrossRef
Biliäre Karzinome: Zielstrukturen für eine molekulare Systemtherapie
Sabrina Voesch, Michael Bitzer, Nisar Peter Malek
Deutsches Ärzteblatt Online.2021;[Epub]     CrossRef
Treatment of advanced gallbladder cancer: A SEER‐based study
Weipu Mao, Fang Deng, Dongyan Wang, Li Gao, Xiuquan Shi
Cancer Medicine.2020; 9(1): 141.     CrossRef
LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma
Sheng Shen, Jiwen Wang, Bohao Zheng, Ying Tao, Min Li, Yueqi Wang, Xiaoling Ni, Tao Suo, Houbao Liu, Han Liu, Jiwei Zhang
Molecular Therapy - Nucleic Acids.2020; 19: 446.     CrossRef
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
Jonathan D Mizrahi, Valerie Gunchick, Kabir Mody, Lianchun Xiao, Phanikeerthi Surapaneni, Rachna T Shroff, Vaibhav Sahai
World Journal of Gastrointestinal Oncology.2020; 12(1): 83.     CrossRef
Low immune index correlates with favorable prognosis but with reduced benefit from chemotherapy in gallbladder cancer
Jie Wang, Xiaobo Bo, Changcheng Wang, Yanlei Xin, Lingxi Nan, Rongkui Luo, Lingli Chen, Xiao Shi, Tao Suo, Xiaoling Ni, Han Liu, Sheng Shen, Min Li, Pinxiang Lu, Yueqi Wang, Houbao Liu
Cancer Science.2020; 111(1): 219.     CrossRef
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
Jonathan D Mizrahi, Valerie Gunchick, Kabir Mody, Lianchun Xiao, Phanikeerthi Surapaneni, Rachna T Shroff, Vaibhav Sahai
World Journal of Gastrointestinal Oncology.2020; 12(1): 83.     CrossRef
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer
Mansi Arora, James M. Bogenberger, Amro Abdelrahman, Jennifer L. Leiting, Xianfeng Chen, Jan B. Egan, Aradhana Kasimsetty, Elzbieta Lenkiewicz, Smriti Malasi, Pedro Luiz Serrano Uson, Bolni Marius Nagalo, Yumei Zhou, Marcela A. Salomao, Heidi E. Kosiorek,
Cancer Chemotherapy and Pharmacology.2020; 85(6): 1063.     CrossRef
NUC-1031 in biliary tract cancer: from bench to bedside and back?
Lenka N. C. Boyd, Godefridus J. Peters, Geert Kazemier, Elisa Giovannetti
Cancer Chemotherapy and Pharmacology.2020; 85(6): 1011.     CrossRef
Targeting cancer stem cells in cholangiocarcinoma (Review)
Nicole Mcgrath, Jianyang Fu, Sophie Gu, Changqing Xie
International Journal of Oncology.2020; 57(2): 397.     CrossRef
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
Makoto Ueno, Masafumi Ikeda, Takashi Sasaki, Fumio Nagashima, Nobumasa Mizuno, Satoshi Shimizu, Hiroki Ikezawa, Nozomi Hayata, Ryo Nakajima, Chigusa Morizane
BMC Cancer.2020;[Epub]     CrossRef
Combined treatment for locally advanced cholangiocellular liver cancer - the case report
A. N. Polyakov, Yu. I. Patyutko, A. Yu. Syskova, K. A. Romanova, I. S. Bazin, O. N. Sergeeva, E. R. Virshke, E. S. Makarov, E. Yu. Antonova, A. A. Kirshin, D. V. Podluzhnyi
Research and Practical Medicine Journal.2019; 6(4): 158.     CrossRef
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin
J. Dierks, M. P. Gaspersz, A. Belkouz, J. L. A. van Vugt, R. J. S. Coelen, J. W. B. de Groot, A. J. ten Tije, W. G. Meijer, J. F. M. Pruijt, T. van Voorthuizen, D. J. van Spronsen, M. Rentinck, D. ten Oever, J. M. Smit, H. M. Otten, T. M. van Gulik, J. W.
Acta Oncologica.2018; 57(6): 807.     CrossRef
Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
Jae Woo Lee, Yong-Tae Kim, Sang Hyub Lee, Jun Hyuk Son, Jin Woo Kang, Ji Kon Ryu, Dong Kee Jang, Woo Hyun Paik, Ban Seok Lee
Gut and Liver.2018; 12(1): 102.     CrossRef
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
Xiaobo Bo, Jie Wang, Tao Suo, Xiaoling Ni, Han Liu, Sheng Shen, Min Li, Yueqi Wang, Houbao Liu, Jiejie Xu
BMC Cancer.2018;[Epub]     CrossRef
Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction
Jun Hyuk Son, Hee Seung Lee, Sang Hyub Lee, Seungmin Bang, Jinwoo Kang, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim
Hepatobiliary & Pancreatic Diseases International.2018; 17(5): 437.     CrossRef
Aktueller Therapiealgorithmus des intrahepatischen cholangiozellulären Karzinoms
G. Lurje, J. Bednarsch, C. Roderburg, C. Trautwein, U. P. Neumann
Der Chirurg.2018; 89(11): 858.     CrossRef
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer
Gaya Spolverato, Fabio Bagante, Cecilia G. Ethun, George Poultsides, Thuy Tran, Kamran Idrees, Chelsea A. Isom, Ryan C. Fields, Bradley Krasnick, Emily Winslow, Clifford Cho, Robert C. G. Martin, Charles R. Scoggins, Perry Shen, Harveshp D. Mogal, Carl Sc
World Journal of Surgery.2017; 41(1): 224.     CrossRef
Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study
Tulay Kus, Gokmen Aktas, Mehmet Emin Kalender, Alper Sevinc, Celaletdin Camci
Journal of Gastrointestinal Cancer.2017; 48(2): 170.     CrossRef
SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts
Changzheng Wang, Hongwei Lv, Wen Yang, Ting Li, Tian Fang, Guishuai Lv, Qin Han, Liwei Dong, Tianyi Jiang, Beige Jiang, Guangshun Yang, Hongyang Wang
Cancer Letters.2017; 398: 1.     CrossRef
Prospective multicenter phase II study of gemcitabine plus cisplatin in patients with unresectable gallbladder cancer
Yoshiki Hirooka, Takuya Ishikawa, Hiroki Kawashima, Eizaburo Ohno, Koji Nonogaki, Akira Kanamori, Takanori Hirai, Hiroki Uchida, Osamu Shirai, Hideki Ishikawa, Hidemi Goto
Cancer Chemotherapy and Pharmacology.2017; 80(1): 119.     CrossRef
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang
Cancer Research and Treatment.2017; 49(3): 807.     CrossRef
Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients
Bum Jun Kim, Jaewon Hyung, Changhoon Yoo, Kyu-pyo Kim, Seong-Joon Park, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Hyungwoo Cho, Baek-Yeol Ryoo, Heung-Moon Chang
Cancer Chemotherapy and Pharmacology.2017; 80(1): 209.     CrossRef
Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis
Jonghun John Lee, Sebastian T Schindera, Hyun-Jung Jang, Scott Fung, Tae Kyoung Kim
Abdominal Radiology.2017; 42(12): 2898.     CrossRef
Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
Byoung Hyuck Kim, Eui Kyu Chie, Kyubo Kim, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang, Sung W. Ha
Oncotarget.2017; 8(44): 78076.     CrossRef
The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis
Xin-Fang Sun, Zhi-Kuan He, Jin-Ping Sun, Quan-Xing Ge, Er-Dong Shen
Oncotarget.2017; 8(59): 100657.     CrossRef
Gemcitabine and cisplatin in inoperable, loco-regionally advanced and metastatic gallbladder cancer: A study from Northern India cancer institute
Vineet Talwar, Shubhra Raina, Varun Goel, Dinesh C. Doval
International Journal of Hepatobiliary and Pancreatic Diseases.2017; 7(2): 1.     CrossRef
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
Nai-Jung Chiang, Chiun Hsu, Jen-Shi Chen, Hsiao-Hui Tsou, Ying-Ying Shen, Yee Chao, Ming-Huang Chen, Ta-Sen Yeh, Yan-Shen Shan, Shiu-Feng Huang, Li-Tzong Chen
Scientific Reports.2016;[Epub]     CrossRef
Chemotherapy for advanced biliary tract carcinoma
Lawrence Chen, Chiehfeng Chen, Yun Yen, Ka-Wai Tam
Medicine.2016; 95(33): e4584.     CrossRef
The role of microRNAs in gallbladder cancer
GANGHUA YANG, LEI ZHANG, RUIXIANG LI, LIN WANG
Molecular and Clinical Oncology.2016; 5(1): 7.     CrossRef